Patient Information Sheet: Galantamine hydrobromide (marketed as Reminyl)FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER2005]: FDA and other international health authorities are reviewing the safety of Razadyne after data from two clinical studies indicated that people taking the drug had a higher death rate than those taking a placebo (sugar pill). Based on this information, FDA has asked the manufacturer to revise the labeling. Please ask your healthcare provider if Razadyne is right for you.